Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |